Упрощенная HTML-версия
38. Aabakken L. Non-steroidal anti-inflammatory drug-induced disease in the distal
ileum and large bowel / L. Aabakken, M. Osnes // Scand. J. Gastroenterol. Suppl. – 1989. Vol. 163.
– P. 48-55.
39. Aabakken L. Small-bowel side-effects of non-steroidal anti-inflammatory drugs / L.
Aabakken // Eur. J. Gastroenterol. Hepatol. – 1999. Vol. 11, № 4. – Р. 383-388.
40. Adebayo D. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically
more important than NSAID gastropathy? / D. Adebayo, I. Bjarnason I // Postgrad. Med J. 2006.
Vol. 82, № 965. – Р. 186-191.
41. Administration of L-arginine reduces the delay of the healing process caused by
ibuprofen. Implication of COX and growth factors expression // S. Sanchez-Fidalgo, I. Martin-
Lacave, M. Illanes et al. // Histol. Histopathol. – 2005. –Vol. 20,№2. – Р. 437-447.
42. Anti-inflammatory activity and gastric lesions induced by zinc-tenoxicam / J.W.
Nascimento, L.N. Santos, M.S. Nothenberg et al. // Pharmacology. – 2003. –Vol.68,№2. – Р.64-69.
43. Anti-inflammatory and antipyretic properties of Clerodendrum petasites S. Moore /
A. Panthong, D. Kanjanapothi, T. Taesotikul et al. // J. Ethnopharmacol. – 2003. – Vol.85,№1. – Р.
151-156.
44. Anti-inflammatory and antiulcerogenic effects of the aqueous extract of Lobaria
pulmonaria (L.) Hoffm / H. Suleyman, F. Odabasoglu, A. Aslan et al. // Phytomedicine. – 2003. –
Vol.10,№6-7. – Р. 552-557.
45. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-
2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats / M.
Tachibana, N. Inoue, T. Yoshida et al. // Pharmacology. – 2003. – Vol. 68,№2. – Р. 96-104.
46. Anti-inflammatory, antinociceptive and ulcerogenic activity of a zinc-diclofenac
complex in rats / L.H. Santos, C.A. Feres, F.H. Melo et al. // Braz. J. Med. Biol. Res. –2004. – Vol.
37,№8. – Р. 1205-1213.
47. Antiulcer activity of methanol fraction of Barleria lupulina Lindl. in animal models /
V. Suba, T. Murugesan, M. Pal et al. // Phytother. Res.- 2004. – Vol.18,№11. –Р. 925-929.
48. Antiulcer activity of Utleria salicifolia rhizome extract / C.V. Rao, S.K. Ojha, K.
Radhakrishnan et al. // J. Ethnopharmacol. – 2004. – Vol.91,№2-3. – Р. 243-249.
49. Ara C. Protective effect of resveratrol against oxidative stress in cholestasis / C. Ara,
H. Kirimlioglu, A.B. Karabulut et al. // J. Surg. Res. – 2005. Vol. 127, № 2. Р. 112-117.
50. Arteriosclerosis and gastoduodenal ulcer / K. Yakabi, H. Kamiichi, S. Ohno et al. //
Nippon. Rinsho. – 2004. – Vol. 62,№3. – Р. 525-531.
51. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2
inhibitors to aggravate gastric damage and inflammation / J.L. Wallace, S.R. Zamuner, W.
McKnight et al. // Am. J. Physiol. Gastrointest. Liver. Physiol. – 2004. – Vol. 286,№1. – Р. 76-81.
52. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients
with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis
Long-term (MEDAL) programme: a randomised comparison / L. Laine, S.P. Curtis, B. Cryer et al. //
Lancet. – 2007. – Vol. 369, №9560. – Р. 465-473.
53. Bannwarth B. Gastrointestinal tolerance of nonsteroidal anti-inflammatory agents / B.
Bannwarth // Drugs. – 2000. Vol. 59, N 1. –P. 17-23.
54. Barrios J.M. Role of biliary phosphatidylcholine in bile acid protection and NSAID
injury of the ileal mucosa in rats / J.M. Barrios, L.M. Lichtenberger // Gastroenterology. - 2000. -
Vol. 118, № 6. Р. 1179-1186.
55. Bjarnason I. Influence of anti-rheumatic drugs on gut permeability and on the gut
associated lymphoid tissue / I. Bjarnason, T.J. Peters // Baillieres. Clin. Rheumatol. - 1996. - Vol.
10, № 1. – Р. 165-176.